🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "specific measures to deal with cost of living challenges" in the upcoming financial statement.

In comments to media outlets, she noted that reducing inflation is a shared task of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 industrialized countries this year and next.

Potential Utility Cost Measures

Sources suggest the administration could take action to reduce energy bills, for example by slashing the current 5% rate of value-added tax charged on energy supplies.

A further option is to lower some of the government charges currently added to bills.

Fiscal Limitations and Expert Expectations

The administration will obtain the next draft from the official forecaster, the OBR, on Monday, which will reveal how much space there is for such measures.

The view from the majority of economists is that Reeves will have to declare tax rises or spending cuts in order to meet her self-imposed borrowing rules.

Earlier on the same day, analysis showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the lower end of projections.

"There's a joint job between the Bank of England and the government to further reduce some of the sources of price increases," the Chancellor told reporters in Washington, at the conferences of the IMF and World Bank.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on expected tax increases, the Treasury chief said the most recent figures from the OBR had not altered her pledge to campaign commitments not to increase tax levels on earnings tax, VAT or National Insurance.

She attributed an "uncertain world" with increasing international and commercial issues for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Economic Tensions

Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "Our national security invariably are paramount."

Last week's statement by China to strengthen trade restrictions on critical minerals and other resources that are crucial for high-technology production led American leader the US President to suggest an further 100% import tax on imports from China, raising the possibility of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary called the Chinese action "economic coercion" and "a international production power grab."

Questioned on accepting the American proposal to participate in its battle with China, the Chancellor said she was "deeply worried" by Chinese actions and encouraged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "harmful for the world economy and generates further headwinds."

"In my view there are areas where we should challenge China, but there are also significant prospects to sell into Chinese markets, including financial services and other sectors of the economy. We've got to get that balance right."

The chancellor also stated she was cooperating with G7 counterparts "regarding our own critical minerals strategy, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also acknowledged that the price the National Health Service spends on pharmaceuticals could go up as a result of ongoing negotiations with the US government and its drugs companies, in return for lower tariffs and capital.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or abandoning operations in the United Kingdom, with several blaming the modest returns they are obtaining.

Last month, the Science Minister said the cost the health service pays for medicines would must increase to halt businesses and drug research funding leaving the United Kingdom.

The Chancellor stated to media: "It has been observed due to the payment system, that clinical trials, new drugs have not been provided in the United Kingdom in the way that they are in other EU nations."

"The objective is to make sure that patients getting treatment from the National Health Service are able to receive the top critical drugs in the world. And so we are reviewing these issues, and... looking to obtain increased investment into the UK."